Kinesiophobia in Prostate Cancer

Sponsor

Selcuk University (Other)

Overall Status

Enrolling by invitation

CT.gov ID

NCT06131853

Collaborator

(none)

Enrollment

Location

Anticipated Duration (Days)

60.9

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study aimed to investigate the effects of prostate cancer on patients' physical activity, kinesiophobia, fatigue and functionality.

This research is a prospective study to be conducted on volunteer individuals between the ages of 40-75. People diagnosed with prostate cancer (study group) and healthy adults who have not been diagnosed with prostate cancer before (control group) will be included in the study. The demographic characteristics, physical activity levels and quality of life of all individuals participating in the study will be evaluated with an online form. In demographic data, physical, sociodemographic data such as age (years), height (cm), body weight (kg), body mass index (kg/m2) and disease-specific information will be recorded. Physical activity level will be measured with the International Physical Activity Survey short form (UFAA), fatigue with the Functional Evaluation of Chronic Disease Treatment-Fatigue Questionnaire, fear of movement with the Causes of Fear of Movement Questionnaire, and quality of life with the Functional Evaluation of Cancer Treatment-Prostate Version questionnaire (KHTFD-Y).

Condition or Disease	Intervention/Treatment	Phase
Prostate Cancer Kinesiophobia Physical Inactivity	Other: survey evaluation

Study Design

Study Type:

Observational [Patient Registry]

Anticipated Enrollment :

50 participants

Observational Model:

Other

Time Perspective:

Prospective

Official Title:

Physical Activity, Fear of Falling, Fatigue and Functionality in Prostate Cancer

Actual Study Start Date :

Nov 9, 2023

Anticipated Primary Completion Date :

Nov 20, 2023

Anticipated Study Completion Date :

Dec 4, 2023

Arms and Interventions

Arm	Intervention/Treatment
prostate group	Other: survey evaluation assessment of physical activity, fatigue, fear of movement, and quality of life
control group	Other: survey evaluation assessment of physical activity, fatigue, fear of movement, and quality of life

Arm

Intervention/Treatment

prostate group

Other: survey evaluation

assessment of physical activity, fatigue, fear of movement, and quality of life

control group

Other: survey evaluation

assessment of physical activity, fatigue, fear of movement, and quality of life

Outcome Measures

Primary Outcome Measures

International Physical Activity Survey short form [10 minutes]
The short form consists of 7 questions. The form provides information about the frequency and time spent in walking, moderate physical activity, and vigorous physical activity.
Functional Assessment of Fatigue Chronic Disease Treatment-Fatigue Questionnaire [10 minutes]
It consists of 13 questions that evaluate the level of fatigue that occurred during daily activities in the last 7 days. Scoring varies between 0-52. High scores indicate less fatigue.
Reasons for Fear of Movement Questionnaire [10 minutes]
It allows the causes of kinesiophobia to be identified and both biological and psychological causes to be determined separately. The average of the scores obtained from the biological and physiological subscales gives the total score from the survey. A 5-point Likert scoring (1 = Totally disagree, 5 = Completely agree) is used in the scale. An individual's high score from the survey indicates that he/she has more fear of movement.
Functional Evaluation of Cancer Treatment-Prostate Version questionnaire [10 minutes]
It consists of 13 questions that evaluate the level of fatigue that occurred during daily activities in the last 7 days. Scoring varies between 0-52. High scores indicate less fatigue.

Eligibility Criteria

Criteria

Ages Eligible for Study:

40 Years to 75 Years

Sexes Eligible for Study:

Male

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

(for prostate cancer-study group)
Being between the ages of 40-75
Want to participate in the study
Being able to read and write
Being diagnosed with prostate cancer by a specialist physician,
Being able to provide their mobility independently,
(for healthy controls - control group)
Being between the ages of 40-75
Not having any previous cancer history and not having undergone cancer surgery
Volunteering to participate in the study

Exclusion Criteria:

Those with a previously known or accompanying diagnosis of dementia
Not wanting to participate in the study
The individual has a disease that may prevent him or her from understanding and completing the survey.
Illiterates
Those who do not want to participate in the research voluntarily
Having active metastasis
Having undergone chemotherapy and radiotherapy in the last 6 months

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Selcuk University	Konya	Selcuklu	Turkey	42130

Sponsors and Collaborators

Selcuk University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Emine Cihan, Asst Prof Dr, Selcuk University

ClinicalTrials.gov Identifier:

NCT06131853

Other Study ID Numbers:

2023/11.09

First Posted:

Nov 14, 2023

Last Update Posted:

Nov 18, 2023

Last Verified:

Nov 1, 2023

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Prostatic Neoplasms

Kinesiophobia

Study Results

No Results Posted as of Nov 18, 2023